MILESTONES EMERGE

As TOMI and SteraMist combatted the SARS-CoV-2 Coronavirus, SteraMist was registered with the Centers for Disease Control in China, the development of SteraBot was announced, the Commercial division was added to TOMI’s operations, record-breaking revenue was achieved, and the TOMI brand achieved widespread recognition and continues to pursue success.

CONTACT US TODAY
close slider
Translate »